The effect of potassium metabolism on acetazolamide-induced teratogenesis.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000086:Acetazolamide / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D000138:Acidosis / Q000139:chemically induced; D000284:Administration, Oral; D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D001639:Bicarbonates / Q000652:urine; D005260:Female; D005552:Forelimb / Q000002:abnormalities; D007279:Injections, Subcutaneous; D007668:Kidney / Q000502:physiology; D008099:Liver / Q000032:analysis; D009132:Muscles / Q000032:analysis; D011188:Potassium / Q000032:analysis / Q000097:blood / Q000378:metabolism* / Q000652:urine; D011191:Potassium Deficiency / Q000139:chemically induced; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced; D051381:Rats; D012964:Sodium / Q000652:urine; D014223:Triamterene / Q000494:pharmacology
D001639:Bicarbonates; D000584:Amiloride; D012964:Sodium; D000086:Acetazolamide; D011188:Potassium; D014223:Triamterene